Released Aug 15, 2011, after the close
10-Q filed Aug 15, 2011, 46 days after period end · 0000950123-11-077641
Q2 2011 · 10-Q
Revenue—
Net Income-$3.75M-$3.75M N/M vs Q2 2010N/M vs Q1 2011
EPS Diluted-$0.10-$0.10 N/M vs Q2 2010N/M vs Q1 2011
Operating Income-$4,622,000N/M
Operating Cash Flowderived-$4,059,000—
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q2 2011 | Q2 2010 |
|---|---|---|
| Net Income | -$3.75M | -$2.14M |
| EPS Diluted | -$0.10 | -$0.12 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
SELLAS Life Sciences Group, Inc. · CIK 1390478 · Engraved from SEC EDGAR